Quantcast

Latest Glycogen storage disease type II Stories

2008-10-17 15:00:23

Genzyme Corporation (Nasdaq: GENZ) today announced that its U.S.

2008-08-07 18:01:54

CRANBURY, N.J., Aug. 7 /PRNewswire-FirstCall/ -- Amicus Therapeutics , a biopharmaceutical company developing small molecule, orally-administered pharmacological chaperones for the treatment of human genetic diseases, today announced financial results for the second quarter of 2008.

2008-07-31 09:01:26

CRANBURY, N.J., July 31 /PRNewswire-FirstCall/ -- Amicus Therapeutics , a biopharmaceutical company developing small molecule, orally-administered pharmacological chaperones for the treatment of human genetic diseases, will announce second quarter 2008 financial results after the regular close of markets on Thursday, August 7, 2008.

2006-04-28 16:40:00

By Lisa Richwine WASHINGTON (Reuters) - The first drug to treat a rare, debilitating muscle disease that can kill infants within a year won U.S. approval on Friday, health officials said. Genzyme Corp.


Word of the Day
tourtiere
  • a meat pie that is usually eaten at Christmas in Quebec
The word 'tourtiere' comes from the French tourte, or passenger pigeon.
Related